FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092500 [Registered on: 06/08/2025] Trial Registered Prospectively
Last Modified On: 05/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Assessment of Accuracy of Smart Scope Screening device for Cervical Cancer  
Scientific Title of Study   Assessment of Predictive Accuracy of Indian-Make Artificial intelligence enabled Smart Scope as Point-of-Care Screening and Triaging tool for Cervical Cancer Screening  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ritu Sharma  
Designation  Professor and Head of Department of Obstetrics and Gynaecology  
Affiliation  Government Institute of Medical Sciences (GIMS) 
Address  Room no. 4152, 4rth floor, Department of Obstetrics and Gynaecology Government Institute of Medical Sciences (GIMS) Greater Noida

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9717001590  
Fax    
Email  drritu661@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Garima Singh 
Designation  PG Student 
Affiliation  Government Institute of Medical Sciences(GIMS) 
Address  Department of Obstetrics and Gynaecology Government Institute of Medical Sciences (GIMS) Greater Noida

Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9794371207  
Fax    
Email  garima002singh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Garima Singh 
Designation  PG Student 
Affiliation  Government Institute of Medical Sciences(GIMS) 
Address  Department of Obstetrics and Gynaecology Government Institute of Medical Sciences (GIMS) Greater Noida


UTTAR PRADESH
201310
India 
Phone  9794371207  
Fax    
Email  garima002singh@gmail.com  
 
Source of Monetary or Material Support  
Government Institute of Medical Sciences(GIMS) Kasna Greater Noida pin 201310 
 
Primary Sponsor  
Name  Government Institute of Medical Sciences(GIMS) 
Address  Government Institute of Medical Sciences(GIMS) Kasna Greater Noida pin 201310 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ritu Sharma  Government Institute of Medical Sciences (GIMS)   Department of Obstetrics and Gynaecology Government Institute of Medical Sciences (GIMS) Greater Noida
Gautam Buddha Nagar
UTTAR PRADESH 
9717001590

drritu661@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee GIMS Greater Noida  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N72||Inflammatory disease of cervix uteri,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1.Sexually active women aged between 25 and 65 years.
2.Women presenting with complaints of white discharge per vagina, vaginal itching, or lower abdominal pain.
3.Women with abnormal per vaginal bleeding.
4.Women found to have a clinically unhealthy cervix on per speculum examination.
 
 
ExclusionCriteria 
Details  1.Pregnant women.
2.Women with a history of prior treatment for cervical cancer.
3.Women with a history of hysterectomy.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To assess the sensitivity, specificity, NPV, and PPV of Artificial intelligence enabled Smart Scope (AI-SS), Visual Inspection after Acetic acid application VIA/ Visual Inspection after Lugol’s Iodine application VILI, and colposcopy in comparison with histopathology.
2.To compare the sensitivity, specificity, NPV, and PPV of Artificial intelligence enabled Smart Scope (AI-SS) with that of the Visual Inspection after Acetic acid application VIA/ Visual Inspection after Lugol’s Iodine application VILI and colposcopy.
 
From baseline to end of study at day7 week 1 
 
Secondary Outcome  
Outcome  TimePoints 
1.To assess the sensitivity, specificity, NPV, and PPV of PAPs in comparison with histopathology.
2.To assess satisfaction of healthcare workers to the Smart Scope procedure.
 
From baseline to end of study at day 7 week 1 
 
Target Sample Size   Total Sample Size="160"
Sample Size from India="160" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

MATERIALS AND METHODS

Study Design:  Prospective observational study

Study Setting: Department of Obstetrics and Gynaecology, Government Institute of Medical

Sciences (GIMS), Greater Noida, Uttar Pradesh

Study Duration: 12 months

Study Population:  Women attending the gynaecology outpatient department (OPD) at GIMS.

 Inclusion Criteria:

1.      Sexually active women aged between 25 and 65 years.

2.      Women presenting with complaints of white discharge per vagina, vaginal itching, or lower abdominal pain. 

3.      Women with abnormal per vaginal bleeding.

4.      Women found to have a clinically unhealthy cervix on per speculum examination.

 Exclusion Criteria:

1.      Pregnant women.

2.      Women with a history of prior treatment for cervical cancer.

3.      Women with a history of hysterectomy.


 
Close